A
Price
$121.38
Change
+$0.72 (+0.60%)
Updated
Jul 3 closing price
Capitalization
42.66B
45 days until earnings call
VREX
Price
$8.80
Change
+$0.08 (+0.92%)
Updated
Jul 3 closing price
Capitalization
732.76M
32 days until earnings call
Interact to see
Advertisement

A vs VREX

Header iconA vs VREX Comparison
Open Charts A vs VREXBanner chart's image
Agilent Technologies
Price$121.38
Change+$0.72 (+0.60%)
Volume$944.96K
Capitalization42.66B
Varex Imaging
Price$8.80
Change+$0.08 (+0.92%)
Volume$148.91K
Capitalization732.76M
A vs VREX Comparison Chart in %
Loading...
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VREX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
A vs. VREX commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Buy and VREX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (A: $121.38 vs. VREX: $8.80)
Brand notoriety: A and VREX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 46% vs. VREX: 33%
Market capitalization -- A: $42.66B vs. VREX: $732.76M
A [@Medical Specialties] is valued at $42.66B. VREX’s [@Medical Specialties] market capitalization is $732.76M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 1 FA rating(s) are green whileVREX’s FA Score has 0 green FA rating(s).

  • A’s FA Score: 1 green, 4 red.
  • VREX’s FA Score: 0 green, 5 red.
According to our system of comparison, A is a better buy in the long-term than VREX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 4 TA indicator(s) are bullish while VREX’s TA Score has 6 bullish TA indicator(s).

  • A’s TA Score: 4 bullish, 4 bearish.
  • VREX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VREX is a better buy in the short-term than A.

Price Growth

A (@Medical Specialties) experienced а +1.86% price change this week, while VREX (@Medical Specialties) price change was +3.04% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.95%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was -0.02%.

Reported Earning Dates

A is expected to report earnings on Aug 19, 2025.

VREX is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Medical Specialties (+1.95% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($42.7B) has a higher market cap than VREX($733M). A has higher P/E ratio than VREX: A (34.82) vs VREX (18.22). A YTD gains are higher at: -9.264 vs. VREX (-39.685). A has higher annual earnings (EBITDA): 1.69B vs. VREX (85.6M). VREX has less debt than A: VREX (470M) vs A (2.56B). A has higher revenues than VREX: A (6.74B) vs VREX (878M).
AVREXA / VREX
Capitalization42.7B733M5,825%
EBITDA1.69B85.6M1,974%
Gain YTD-9.264-39.68523%
P/E Ratio34.8218.22191%
Revenue6.74B878M767%
Total CashN/A141M-
Total Debt2.56B470M544%
FUNDAMENTALS RATINGS
A vs VREX: Fundamental Ratings
A
VREX
OUTLOOK RATING
1..100
3224
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
85
Overvalued
PROFIT vs RISK RATING
1..100
64100
SMR RATING
1..100
4792
PRICE GROWTH RATING
1..100
5262
P/E GROWTH RATING
1..100
5742
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (20) in the Biotechnology industry is somewhat better than the same rating for VREX (85) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than VREX’s over the last 12 months.

A's Profit vs Risk Rating (64) in the Biotechnology industry is somewhat better than the same rating for VREX (100) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than VREX’s over the last 12 months.

A's SMR Rating (47) in the Biotechnology industry is somewhat better than the same rating for VREX (92) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than VREX’s over the last 12 months.

A's Price Growth Rating (52) in the Biotechnology industry is in the same range as VREX (62) in the Medical Specialties industry. This means that A’s stock grew similarly to VREX’s over the last 12 months.

VREX's P/E Growth Rating (42) in the Medical Specialties industry is in the same range as A (57) in the Biotechnology industry. This means that VREX’s stock grew similarly to A’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVREX
RSI
ODDS (%)
Bearish Trend 2 days ago
46%
Bearish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
64%
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
63%
Declines
ODDS (%)
Bearish Trend 5 days ago
60%
Bearish Trend 17 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VREX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SCHM28.710.16
+0.56%
Schwab US Mid-Cap ETF™
PGHY19.900.04
+0.20%
Invesco Glb ex-US High Yld Corp Bd ETF
OEUR32.68-0.04
-0.13%
ALPS O'Shares Europe Quality Div ETF
GIGB45.77-0.10
-0.21%
Goldman Sachs Acss Invmt Grd Corp Bd ETF
YQQQ13.88-0.19
-1.32%
YieldMax Short N100 Option Inc Strgy ETF

A and

Correlation & Price change

A.I.dvisor indicates that over the last year, A has been closely correlated with MTD. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if A jumps, then MTD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To A
1D Price
Change %
A100%
+0.60%
MTD - A
85%
Closely correlated
+0.28%
WAT - A
82%
Closely correlated
-0.48%
RVTY - A
80%
Closely correlated
+0.41%
TMO - A
79%
Closely correlated
+1.86%
BRKR - A
78%
Closely correlated
-0.02%
More

VREX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VREX has been loosely correlated with NVST. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if VREX jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VREX
1D Price
Change %
VREX100%
+0.92%
NVST - VREX
51%
Loosely correlated
+1.09%
ATR - VREX
49%
Loosely correlated
+0.45%
GMED - VREX
49%
Loosely correlated
-2.31%
A - VREX
46%
Loosely correlated
+0.60%
IRMD - VREX
45%
Loosely correlated
+0.42%
More